Dale A. Sander, the CFO and Chief Corp. Deve. Off. of $HUMA, bought 20,000 shares of the company on 04-10-2025 for an estimated $30,600. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 97.1%. Following this trade, they now own 40,600 shares of this class of $HUMA stock.
$HUMA Insider Trading Activity
$HUMA insiders have traded $HUMA stock on the open market 14 times in the past 6 months. Of those trades, 8 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $HUMA stock by insiders over the last 6 months:
- BRADY W DOUGAN has made 1 purchase buying 1,797 shares for an estimated $7,978 and 3 sales selling 1,500,000 shares for an estimated $6,606,799.
- LAURA E NIKLASON (President, CEO and Director) has made 1 purchase buying 1,797 shares for an estimated $7,978 and 3 sales selling 1,500,000 shares for an estimated $6,606,799.
- KATHLEEN SEBELIUS purchased 50,000 shares for an estimated $66,000
- MICHAEL T. CONSTANTINO has made 2 purchases buying 20,600 shares for an estimated $40,341 and 0 sales.
- DALE A. SANDER (CFO and Chief Corp. Deve. Off.) purchased 20,000 shares for an estimated $30,600
- SHAMIK J PARIKH (Chief Medical Officer) purchased 7,500 shares for an estimated $11,625
- CHARLES BRUCE GREEN purchased 6,000 shares for an estimated $7,740
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HUMA Hedge Fund Activity
We have seen 88 institutional investors add shares of $HUMA stock to their portfolio, and 61 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WOODLINE PARTNERS LP added 2,000,268 shares (+235.7%) to their portfolio in Q4 2024, for an estimated $10,101,353
- CENTERBOOK PARTNERS LP added 1,279,839 shares (+inf%) to their portfolio in Q4 2024, for an estimated $6,463,186
- UBS GROUP AG added 937,539 shares (+509.5%) to their portfolio in Q4 2024, for an estimated $4,734,571
- BREVAN HOWARD CAPITAL MANAGEMENT LP added 846,070 shares (+2795.1%) to their portfolio in Q4 2024, for an estimated $4,272,653
- VOLORIDGE INVESTMENT MANAGEMENT, LLC removed 760,738 shares (-60.4%) from their portfolio in Q4 2024, for an estimated $3,841,726
- VANGUARD GROUP INC added 543,995 shares (+10.8%) to their portfolio in Q4 2024, for an estimated $2,747,174
- MONASHEE INVESTMENT MANAGEMENT LLC removed 535,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $2,701,750
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$HUMA Analyst Ratings
Wall Street analysts have issued reports on $HUMA in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- H.C. Wainwright issued a "Buy" rating on 11/05/2024
- Cowen & Co. issued a "Buy" rating on 10/18/2024
- BTIG issued a "Buy" rating on 10/18/2024
To track analyst ratings and price targets for $HUMA, check out Quiver Quantitative's $HUMA forecast page.
$HUMA Price Targets
Multiple analysts have issued price targets for $HUMA recently. We have seen 2 analysts offer price targets for $HUMA in the last 6 months, with a median target of $8.0.
Here are some recent targets:
- Matt O'Brien from Piper Sandler set a target price of $6.0 on 10/18/2024
- Ryan Zimmerman from BTIG set a target price of $10.0 on 10/18/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
